AUTOLUS THERAPEUTICS ($AUTL) posted quarterly earnings results on Tuesday, August 12th. The company reported earnings of -$0.18 per share, beating estimates of -$0.24 by $0.06. The company also reported revenue of $20,920,000, beating estimates of $13,163,355 by $7,756,645.
You can see Quiver Quantitative's $AUTL stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AUTOLUS THERAPEUTICS Hedge Fund Activity
We have seen 41 institutional investors add shares of AUTOLUS THERAPEUTICS stock to their portfolio, and 63 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 5,469,922 shares (-35.0%) from their portfolio in Q1 2025, for an estimated $8,478,379
- DEEP TRACK CAPITAL, LP added 3,630,579 shares (+25.5%) to their portfolio in Q1 2025, for an estimated $5,627,397
- CANDRIAM S.C.A. removed 3,191,401 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $7,276,394
- ARMISTICE CAPITAL, LLC added 1,800,000 shares (+19.6%) to their portfolio in Q1 2025, for an estimated $2,790,000
- WELLINGTON MANAGEMENT GROUP LLP added 1,746,020 shares (+6.9%) to their portfolio in Q1 2025, for an estimated $2,706,331
- BANK OF NEW YORK MELLON CORP removed 1,673,994 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,594,690
- AFFINITY ASSET ADVISORS, LLC removed 1,455,000 shares (-32.3%) from their portfolio in Q1 2025, for an estimated $2,255,250
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AUTOLUS THERAPEUTICS Analyst Ratings
Wall Street analysts have issued reports on $AUTL in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 07/21/2025
- Truist Securities issued a "Buy" rating on 04/01/2025
- Wells Fargo issued a "Overweight" rating on 03/21/2025
To track analyst ratings and price targets for AUTOLUS THERAPEUTICS, check out Quiver Quantitative's $AUTL forecast page.
AUTOLUS THERAPEUTICS Price Targets
Multiple analysts have issued price targets for $AUTL recently. We have seen 3 analysts offer price targets for $AUTL in the last 6 months, with a median target of $10.0.
Here are some recent targets:
- Gil Blum from Needham set a target price of $10.0 on 07/21/2025
- Asthika Goonewardene from Truist Securities set a target price of $10.0 on 04/01/2025
- Yanan Zhu from Wells Fargo set a target price of $6.0 on 03/21/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
